Out of nowhere Geron Corporation announced last week it was not only halting the first clinical trial of embryonic stem cell treatment on humans but getting out of the embryonic stem cell business altogether. To understand how big a blow to the embryonic stem cell industry this was, you first must know it was Geron […]